Literature DB >> 28496693

Ablation of Atrial Fibrillation in the Elderly: Current Evidence and Evolving Trends.

Suraj Kapa1, Rupa Bala1.   

Abstract

Management of atrial fibrillation in the elderly presents unique challenges, including deciding upon the best treatment strategy: rate control versus rhythm control. The decision to pursue one treatment strategy over another is based on understanding the underlying disorder: symptomatology from atrial fibrillation itself versus symptoms due to a rapid ventricular response from atrial fibrillation. The ablation strategies for the treatment of atrial fibrillation include atrioventricular junction ablation and pulmonary vein isolation. This review discusses the data on ablation of atrial fibrillation in the elderly, with an emphasis on issues regarding safety and efficacy in this population.

Entities:  

Year:  2011        PMID： 28496693      PMCID： PMC5153048          DOI： 10.4022/jafib.341

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  52 in total

1.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

2.  Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians.

Authors:  T Jared Bunch; J Peter Weiss; Brian G Crandall; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Donald L Lappe; J Brent Muhlestein; Jennifer Nelson; John D Day
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

Review 3.  Mechanisms of atrial remodeling and clinical relevance.

Authors:  Stanley Nattel; Akiko Shiroshita-Takeshita; Sophie Cardin; Patricia Pelletier
Journal:  Curr Opin Cardiol       Date:  2005-01       Impact factor: 2.161

4.  Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study.

Authors:  Hakan Oral; Aman Chugh; Kristina Lemola; Peter Cheung; Burr Hall; Eric Good; Jihn Han; Kamala Tamirisa; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

Review 5.  Management of the older person with atrial fibrillation.

Authors:  Wilbert S Aronow
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-06       Impact factor: 6.053

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.

Authors:  Matthew R Reynolds; Joshua Walczak; Sarah A White; David J Cohen; David J Wilber
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

8.  Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.

Authors:  C Ozcan; A Jahangir; P A Friedman; P J Patel; T M Munger; R F Rea; M A Lloyd; D L Packer; D O Hodge; B J Gersh; S C Hammill; W K Shen
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

9.  Ontogeny of corticosteroid-binding globulin biosynthesis in the rat.

Authors:  C L Smith; G L Hammond
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

10.  Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly.

Authors:  Erica Zado; David J Callans; Michael Riley; Mathew Hutchinson; Fermin Garcia; Rupa Bala; David Lin; Joshua Cooper; Ralph Verdino; Andrea M Russo; Sanjay Dixit; Edward Gerstenfeld; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.